Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Cardiovascular disease

People with HIV have higher risk of death after heart attack

News
8 October 2013
Side effects

Does efavirenz use raise the risk of suicide in people with HIV?

News
8 October 2013
Bad science & bogus treatments

Circumcision: Cut to Fit

Editor's pick
Poz
8 October 2013
Improving HIV care

Studies look at community vs hospital-based HIV care and medication issues

News
7 October 2013
Treatment outcomes & life expectancy

Liver fibrosis linked to immune activation in HIV/HCV co-infected women

News
7 October 2013
The search for a cure

Gladstone lab uncovers a potential HIV cure — and it's already a drug

Editor's pick
San Francisco Business Times
6 October 2013
PrEP

Long-Acting HIV Antiretrovirals May Be Revolutionary. But Will They Be Worth It?

Editor's pick
The Body Pro
6 October 2013
Injectable & long-acting HIV treatment

Long-acting antiretrovirals may improve survival for people with poor adherence

News
4 October 2013
Cancer

Liver cancer often diagnosed late with poor survival in people with HIV

News
4 October 2013
PrEP science

New integrase inhibitor GSK1265744 safe and well tolerated in eight studies

News
4 October 2013
Treatment guidelines

New recommendations for the medical care of people living with HIV (en français)

Editor's pick
ANRS press release
4 October 2013
Treatment guidelines

France adopts new national policy to test and treat HIV

Editor's pick
Brazilian Ministry of Health
4 October 2013
New & experimental HIV treatments

From sky high to CHAI – what needs to be done about dolutegravir pricing?

Editor's pick
HIV I-Base
2 October 2013
New & experimental HIV treatments

Stribild is effective and well tolerated in older people with HIV

News
2 October 2013
HIV treatment

CROI abstract submission closes 8 October

Editor's pick
CROI 2014
30 September 2013
New & experimental HIV treatments

European Commission Approves Gilead Sciences' Tybost(TM), a New Boosting Agent for HIV Therapy

Editor's pick
Gilead press release
26 September 2013
Adherence

Single-tablet regimen improves antiretroviral adherence and reduces hospitalisation

News
26 September 2013
PrEP

PATH Evaluates Janssen’s Rilpivirine as HIV Infection Prophylactic

Editor's pick
Genetic Engineering & Biotechnology News
25 September 2013
New & experimental HIV treatments

CHMP recommends that Vitekta (elvitegravir) should be granted marketing authorisation

Editor's pick
European Medicines Agency
25 September 2013
The search for a cure

Nail Fungus Drug Might Help Against HIV: Study

Editor's pick
WebMD
25 September 2013
Pharmaceutical industry

Seven Ways to Speed up the HIV Treatment Pipeline

Editor's pick
Positive Lite
24 September 2013
Side effects

Switching from Atripla to Eviplera reduces central nervous system side-effects

News
23 September 2013
New & experimental HIV treatments

Good safety profile with long-acting integrase inhibitor, GSK744

Editor's pick
NATAP
19 September 2013
How HIV works

Gene discovery could lead to new types of HIV treatments

Editor's pick
Reuters
19 September 2013